Novo Nordisk As Stock Market Value
| NVO Stock | USD 123.90 0.61 0.49% |
| Symbol | Novo |
Novo Nordisk AS Price To Book Ratio
Is Novo Nordisk's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.631 | Dividend Share 9.4 | Earnings Share 2.68 | Revenue Per Share 51.812 | Quarterly Revenue Growth 0.37 |
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Novo Nordisk 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novo Nordisk's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novo Nordisk.
| 04/27/2022 |
| 04/16/2024 |
If you would invest 0.00 in Novo Nordisk on April 27, 2022 and sell it all today you would earn a total of 0.00 from holding Novo Nordisk AS or generate 0.0% return on investment in Novo Nordisk over 720 days. Novo Nordisk is related to or competes with PetIQ, Emergent Biosolutions, Neurocrine Biosciences, and Haleon Plc. Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutica... More
Novo Nordisk Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novo Nordisk's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novo Nordisk AS upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.27 | |||
| Information Ratio | 0.0835 | |||
| Maximum Drawdown | 11.35 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 3.72 |
Novo Nordisk Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novo Nordisk's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novo Nordisk's standard deviation. In reality, there are many statistical measures that can use Novo Nordisk historical prices to predict the future Novo Nordisk's volatility.| Risk Adjusted Performance | 0.0794 | |||
| Jensen Alpha | 0.182 | |||
| Total Risk Alpha | 0.0516 | |||
| Sortino Ratio | 0.1278 | |||
| Treynor Ratio | 0.3443 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novo Nordisk's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novo Nordisk AS Backtested Returns
Novo Nordisk appears to be very steady, given 3 months investment horizon. Novo Nordisk AS has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Novo Nordisk, which you can use to evaluate the volatility of the firm. Please exercise Novo Nordisk's Mean Deviation of 1.36, risk adjusted performance of 0.0794, and Downside Deviation of 1.27 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Novo Nordisk holds a performance score of 10. The company secures a Beta (Market Risk) of 0.62, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novo Nordisk's returns are expected to increase less than the market. However, during the bear market, the loss of holding Novo Nordisk is expected to be smaller as well. Please check Novo Nordisk's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Novo Nordisk's current price movements will revert.
Auto-correlation | 0.84 |
Very good predictability
Novo Nordisk AS has very good predictability. Overlapping area represents the amount of predictability between Novo Nordisk time series from 27th of April 2022 to 22nd of April 2023 and 22nd of April 2023 to 16th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novo Nordisk AS price movement. The serial correlation of 0.84 indicates that around 84.0% of current Novo Nordisk price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 268.84 |
Novo Nordisk AS lagged returns against current returns
Autocorrelation, which is Novo Nordisk stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novo Nordisk's stock expected returns. We can calculate the autocorrelation of Novo Nordisk returns to help us make a trade decision. For example, suppose you find that Novo Nordisk has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Novo Nordisk regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novo Nordisk stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novo Nordisk stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novo Nordisk stock over time.
Current vs Lagged Prices |
| Timeline |
Novo Nordisk Lagged Returns
When evaluating Novo Nordisk's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novo Nordisk stock have on its future price. Novo Nordisk autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novo Nordisk autocorrelation shows the relationship between Novo Nordisk stock current value and its past values and can show if there is a momentum factor associated with investing in Novo Nordisk AS.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Novo Nordisk Correlation, Novo Nordisk Volatility and Novo Nordisk Alpha and Beta module to complement your research on Novo Nordisk. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.